ChemRar Group provides Russian scientists with access to one of the world's largest collections of chemical substances ...

This year, a large number of Chinese guests - suppliers of pharmaceutical ingredients , equipment and materials - ...

Actualmente, ChemRar y la empresa mexicana «Distribuidora y Exportadora de Medicamentos, S.A. de C.V. (DIEMSA)» han ...

To ensure technological sovereignty, leading universities could become new “development institutions” that, based on ...

Over the past decade, domestic pharmaceuticals have made a huge leap. But even more ambitious goals are set for it in ...

At the First Moscow State Medical University named after I.M. Sechenov began clinical trials of a drug for the ...

From September 11 to 15, the VI International Forum of Oncology and Radiotherapy “FOR LIFE” took place in Moscow. The ...

Chairman of the Board of Directors of the ChemRar Group Andrey Ivashchenko took part in the business program of the ...

On July 31, 2023, as part of the design and educational intensive “Archipelag 2023” at the “Chelovek+” site, a meeting ...

From July 27 to 28, the Economic and Humanitarian Forum took place in Saint Petersburg as part of the Second ...

Avineiro company of the ChemRar Group announces that it has received a registration certificate from the Russian ...

Elpida, the Russian developer of ELPIDA®, an innovative eslulfavarinin-based drug against HIV, has reduced the price ...